ALDH1 is upregulated in circulating tumor cells and acts as a biomarker for detecting and isolating these cells in patients with cancer recurrence, and its levels are predictive of responses of drug therapy 36, making it possible to target ALDH1-dependent cancers more precisely. The gene discussed is ALDH1A1; the disease is neoplasm.